Subscribe to MDT Magazine News

Phreesia Helps Practices Manage Patients with Uncontrolled Asthma

May 3, 2011 6:32 am | by Bio-Medicine.Org | Comments

NEW YORK, May 3, 2011 /- Phreesia, the patient check-in company, announced the release of an asthma control assessment to all primary care physicians and pediatrics practices in its network. The screening tool is part of Phreesia's automated patient check-in solution and, through a series...

Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today

May 3, 2011 6:31 am | by Bio-Medicine.Org | Comments

MADISON, N.J., May 3, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, announced today that Spark Acquisition Corporation, its wholly owned subsidiary ("Spark"), has extended the expiration of its tender...


Tenet Healthcare 1Q profit falls 17 pct

May 3, 2011 5:45 am | by The Associated Press | Comments

Hospital operator Tenet Healthcare Corp. said Tuesday its first quarter earnings fell 17 percent largely due to increased income taxes that offset admissions gains.The Dallas company, which is the target of a hostile takeover bid by rival Community Health Systems Inc., earned $73 million, or 14...


Amedisys agrees to buy NJ hospice

May 3, 2011 5:45 am | by The Associated Press | Comments

Home health and hospice provider Amedisys Inc. says it has agreed to buy the hospice operations of Hackensack University Medical Center in New Jersey.A sale price was not revealed Tuesday.The hospice operation has one hospice agency and one eight-bed unit that primarily serves Bergen and Hudson...

Civitas taps backers to bump Series A round to $28M

May 3, 2011 5:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Civitas Therapeutics Inc., which launched in January with a $20 million Series A funding round, has now bumped that up to $28 million, according to federal documents.

Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2011 Health Care Conference

May 3, 2011 5:34 am | by Bio-Medicine.Org | Comments

UNION CITY, Calif., May 3, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer,  will present at the Bank of America Merrill Lynch 2011 Health...


CryoLife Completes Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation

May 3, 2011 5:34 am | by Bio-Medicine.Org | Comments

ATLANTA and IRVINE, Calif., May 3, 2011 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, today announced the completion of its tender offer, through its wholly owned subsidiary CL Falcon, Inc., for 49.9 percent of the...


Boston Scientific Announces CE Mark Approval and First Use of Blazerâ„¢ Open-Irrigated Catheter in Europe

May 3, 2011 5:34 am | by Bio-Medicine.Org | Comments

NATICK, Mass., May 3, 2011 /- Boston Scientific Corporation (NYSE: BSX ) today announced CE Mark approval and first use in Europe of its Blazer™ Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as...


GenerationOne Selected by Cincinnati Children's Hospital Medical Center for Mobile Health Pilot with Teen Asthmatics

May 3, 2011 5:33 am | by Bio-Medicine.Org | Comments

MIAMI, May 3, 2011 /- GenerationOne and Cincinnati Children's Hospital Medical Center collaborated on a 14-month clinical trial for testing mobile technology in aiding the management of teenagers with Asthma. "Mobile phones represent an appealing technology for tailoring interventions and...

TomoTherapy Workshops at ESTRO to Focus on Treatment Planning Techniques and Improving Clinical Practice

May 3, 2011 4:45 am | by The Associated Press | Comments () —TomoTherapy Incorporated ( (NASDAQ: TOMO), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced a new feature for its TomoTherapy@ radiation therapy treatment system that...

NIH Awards $5 Million for Development of Hemorrhagic Fever Vaccines

May 3, 2011 4:34 am | by Georgia Tech Institute of Technology | Comments

The National Institutes of Health (NIH) has awarded nearly $5.4 million to a collaborative team of scientists at Emory University, Georgia Institute of Technology and Texas Biomedical Research Institute to develop vaccines for prevention of deadly hemorrhagic fevers.

Medigus presents world?s smallest camera for medical endoscopy based on TSV Packaging

May 3, 2011 1:32 am | by I-Micronews | Comments

Based on advanced CMOS image sensor and Through-Silicon-Vias (TSV) packaging assembly, the camera breaches 1 mm diameter threshold, lowers cost and enables a variety of medical procedures. Medigus targets fast growing market for disposable endoscopy cameras, estimated at over half a...

Althea and Biotest Establish Commercial Filling Agreement

May 2, 2011 11:31 pm | by Bio-Medicine.Org | Comments

SAN DIEGO, May 3, 2011 /- Althea Technologies, Inc. announced today that they have entered into a commercial supply agreement with Biotest Pharmaceuticals Corporation.  Under the terms of the agreement, Althea will fill commercial drug products to supply the U.S. market.  The...


Winner Medical Exhibited its PurCotton Retail Products at MICF 2011 in Beijing

May 2, 2011 11:31 pm | by Bio-Medicine.Org | Comments

SHENZHEN, China, May 3, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ), ("Winner Medical") a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today reported that its...


MRI identifies primary endometrial and cervical cancer

May 2, 2011 9:35 pm | by EurekAlert | Comments

(American Roentgen Ray Society) MRI can determine if a patient has endometrial versus cervical cancer even when a biopsy can't make that distinction, according to a new study. Determining the primary site of a tumor helps determine appropriate cancer treatment.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.